SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-045576
Filing Date
2024-04-10
Accepted
2024-04-10 08:00:28
Documents
17
Period of Report
2024-04-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411482d1_8k.htm   iXBRL 8-K 25588
2 EXHIBIT 5.1 tm2411482d1_ex5-1.htm EX-5.1 10638
3 GRAPHIC image_001.jpg GRAPHIC 17416
4 GRAPHIC image_002.jpg GRAPHIC 9893
5 GRAPHIC image_003.jpg GRAPHIC 1413
  Complete submission text file 0001104659-24-045576.txt   252126

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eyen-20240409.xsd EX-101.SCH 3015
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20240409_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20240409_pre.xml EX-101.PRE 22359
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2411482d1_8k_htm.xml XML 3670
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 24834285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)